跳至主要内容
临床试验/KCT0004822
KCT0004822招募中未知

infectious surgical site Complications after Oral antibiotic Bowel preparation for minimally-invasive Rectal cAncer surgery (COBRA) – multicenter prospective randomized controlled trial

Korea University Ansan Hospital0 个研究点目标入组 438 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
438

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 75(Year)(—)
性别
All

入选标准

  • 1)age 20~75
  • 2) pathologically confirmed rectal adenocarcinoma of which lower margin is located within 15cm from anal verge
  • 3) radiologically confirmed non-metastatic rectal cancer (cTanyNantM0)
  • 4) ECOG performance status 0-2
  • 5) ASA = 3
  • 6) A patient who understands this clinical trial and agrees to be enrolled

排除标准

  • 1) anticipated other organ resection
  • 2) metastatic disease
  • 3) one who have been treated for infections or have taken antibiotics within 2 weeks before surgery
  • 4) severe major organ dysfunction (heart, lung, liver, kidney)
  • 5) A patient who is taking steroid or immunosuppresants
  • 6) inflammatory bowel disease
  • 7) A patient who has undergone chemotherapy within 1 month due to malignant disease of other organ
  • 8) decrease in white blood cell for various reasons
  • 9)pregnant or lactating women
  • 10)local resection of rectal cancer

研究者

相似试验